Bionano Genomics, Inc. Interest Expense
Bionano Genomics, Inc. (BNGO) reported Interest Expense of $122.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-08
- Bionano Genomics, Inc. interest expense for the quarter ending 2024-03-31 was $122.00K, a 60.53% increase year-over-year.
- Bionano Genomics, Inc. interest expense for the quarter ending 2023-12-31 was $4.90M, a 6430.67% increase year-over-year.
- Bionano Genomics, Inc. interest expense for the quarter ending 2023-09-30 was $71.00K, a 2.74% decline year-over-year.
- Bionano Genomics, Inc. interest expense for the quarter ending 2023-06-30 was $74.00K, a 0.00% change year-over-year.
- Bionano Genomics, Inc. interest expense for fiscal 2023 was $5.12M, a 1617.79% increase from fiscal 2022.
- Bionano Genomics, Inc. interest expense for fiscal 2022 was $298.00K, a 67.85% decline from fiscal 2021.
- Bionano Genomics, Inc. interest expense for fiscal 2021 was $927.00K, a 63.20% decline from fiscal 2020.
- Bionano Genomics, Inc. interest expense for fiscal 2020 was $2.52M, a 10.18% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $122.00K 10-Q · filed 2024-05-08 | $5.02M derived: sum of 2 quarters · filed 2024-05-08 | $5.09M derived: sum of 3 quarters · filed 2024-05-08 | $5.17M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.97M derived: sum of 2 quarters · filed 2024-03-05 | $5.04M derived: sum of 3 quarters · filed 2024-03-05 | $5.12M 10-K · filed 2024-03-05 | ||||
| 2023-09-30 | $71.00K 10-Q · filed 2023-11-08 | $145.00K derived: sum of 2 quarters · filed 2023-11-08 | $221.00K 10-Q · filed 2023-11-08 | $296.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-06-30 | $74.00K 10-Q · filed 2023-08-09 | $149.00K 10-Q · filed 2023-08-09 | $225.00K derived: sum of 3 quarters · filed 2024-05-08 | $298.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-03-31 | $76.00K 10-Q · filed 2024-05-08 | $151.00K derived: sum of 2 quarters · filed 2024-05-08 | $224.00K derived: sum of 3 quarters · filed 2024-05-08 | $298.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $148.00K derived: sum of 2 quarters · filed 2024-03-05 | $222.00K derived: sum of 3 quarters · filed 2024-03-05 | $298.00K 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $73.00K 10-Q · filed 2023-11-08 | $147.00K derived: sum of 2 quarters · filed 2023-11-08 | $223.00K 10-Q · filed 2023-11-08 | $278.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $74.00K 10-Q · filed 2023-08-09 | $151.00K 10-Q · filed 2023-08-09 | $205.00K derived: sum of 3 quarters · filed 2023-08-09 | $207.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $77.00K 10-Q · filed 2023-05-09 | $131.00K derived: sum of 2 quarters · filed 2023-05-09 | $133.00K derived: sum of 3 quarters · filed 2023-05-09 | $401.00K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $56.00K derived: sum of 2 quarters · filed 2023-03-09 | $324.00K derived: sum of 3 quarters · filed 2023-03-09 | $927.00K 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-03 | $270.00K derived: sum of 2 quarters · filed 2022-11-03 | $873.00K 10-Q · filed 2022-11-03 | $1.48M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $268.00K 10-Q · filed 2022-08-04 | $210.00K 10-Q · filed 2021-08-04 | $871.00K 10-Q · filed 2022-08-04 | $748.00K 10-Q · filed 2021-08-04 | $1.48M derived: sum of 3 quarters · filed 2022-08-04 | $2.07M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $603.00K 10-Q · filed 2022-05-05 | $538.00K 10-Q · filed 2021-05-13 | $1.21M derived: sum of 2 quarters · filed 2022-05-05 | $1.80M derived: sum of 3 quarters · filed 2022-05-05 | $2.36M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.20M derived: sum of 2 quarters · filed 2022-03-01 | $1.76M derived: sum of 3 quarters · filed 2022-03-01 | $2.52M 10-K · filed 2022-03-01 | $2.52M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $589.00K 10-Q · filed 2020-11-13 | $1.15M derived: sum of 2 quarters · filed 2021-08-04 | $1.91M 10-Q · filed 2020-11-13 | $2.58M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-06-30 | $561.00K 10-Q · filed 2021-08-04 | $1.32M 10-Q · filed 2021-08-04 | $2.00M derived: sum of 3 quarters · filed 2021-08-04 | $2.57M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $761.00K 10-Q · filed 2021-05-13 | $1.43M derived: sum of 2 quarters · filed 2021-05-13 | $2.01M derived: sum of 3 quarters · filed 2021-05-13 | $2.66M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $673.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $1.25M derived: sum of 2 quarters · filed 2021-03-23 | $1.90M derived: sum of 3 quarters · filed 2021-03-23 | $2.29M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $578.00K 10-Q · filed 2020-11-13 | $578.04K 10-Q · filed 2019-11-07 | $1.22M derived: sum of 2 quarters · filed 2020-11-13 | $1.61M 10-Q · filed 2020-11-13 | $1.42M 10-Q · filed 2019-11-07 | $1.76M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $645.00K 10-Q · filed 2020-08-13 | $565.89K 10-Q · filed 2019-08-08 | $959.00K 10-Q · filed 2020-08-13 | $838.39K 10-Q · filed 2019-08-08 | $1.18M derived: sum of 3 quarters · filed 2020-08-13 | $1.59M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $273.00K 10-Q · filed 2020-06-18 | $272.50K 10-Q · filed 2019-05-09 | $539.97K derived: sum of 2 quarters · filed 2020-06-18 | $944.41K derived: sum of 3 quarters · filed 2020-06-18 | $1.35M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | $266.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $671.41K derived: sum of 2 quarters · filed 2020-03-10 | $1.08M derived: sum of 3 quarters · filed 2020-03-10 | $1.38M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $404.44K 10-Q · filed 2019-11-07 | $812.07K derived: sum of 2 quarters · filed 2019-11-07 | $1.11M 10-Q · filed 2019-11-07 | $1.27M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $407.63K 10-Q · filed 2019-08-08 | $709.62K 10-Q · filed 2019-08-08 | $869.14K derived: sum of 3 quarters · filed 2019-08-08 | $1.01M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $301.98K 10-Q · filed 2019-05-09 | $461.50K derived: sum of 2 quarters · filed 2019-05-09 | $606.81K derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | $159.52K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $304.83K derived: sum of 2 quarters · filed 2019-03-14 | $590.93K 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | $145.31K 10-Q · filed 2018-11-07 | $431.40K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |